Jonathan Gilroy

Jonathan Gilroy is currently serving as the Sr. Principal Scientist in Analytical Development at Aimmune Therapeutics since December 2021. Prior to this, Jonathan worked as a CMC Technical Writer & Consultant at Global Regulatory Writing & Consulting, Inc. from December 2019 to December 2021. With a background as a Senior Scientist at Aptevo Therapeutics Inc and Scientist at Seattle Genetics, Jonathan brings a wealth of experience in the pharmaceutical industry. Starting their career as a QC Associate at Bayer, Jonathan has since worked in various analytical roles, including as an Analyst at Bioanalytical Systems, Inc. Jonathan holds a Bachelor of Science in Chemistry from George Fox University.